Literature DB >> 809293

Copper ion binding and enzyme inhibitory properties of the antithyroid drug methimazole.

D P Hanlon, S Shuman.   

Abstract

The antithyroid drug, methimazole (1-methyl-2-thiolimidazole), is a powerful chelator of cupric ion. This is reflected in its ability to selectively inhibit certain copper oxidases. Uricase, ascorbic oxidase and monoamine oxidase are not affected. Ceruloplasmin oxidase is slightly inhibited and tyrosinase is markedly inhibited by methimazole.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809293     DOI: 10.1007/BF02326924

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  5 in total

1.  AN AMINE OXIDASE IN NORMAL HUMAN SERUM.

Authors:  C M MCEWEN; J D COHEN
Journal:  J Lab Clin Med       Date:  1963-11

2.  Mechanisms of antithyroidal activity of methimazole.

Authors:  R E Brock; W F Head
Journal:  J Pharm Sci       Date:  1966-08       Impact factor: 3.534

3.  Inhibition of brain dopamine- -hydroxylase activity by methimazole.

Authors:  J M Stolk; D P Hanlon
Journal:  Life Sci II       Date:  1973-05-08

4.  Evidence that the goitrogen, methimazole, interferes with the extrathyroidal utilization of exogenous thyroxine.

Authors:  J F Van Pilsum; J R Boen; L Bans
Journal:  Endocrinology       Date:  1973-01       Impact factor: 4.736

5.  Interaction of ergothioneine with metal ions and metalloenzymes.

Authors:  D P Hanlon
Journal:  J Med Chem       Date:  1971-11       Impact factor: 7.446

  5 in total
  3 in total

1.  Effect of methimazole on the activity of mushroom tyrosinase.

Authors:  A Andrawis; V Kahn
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

2.  Termination of the respiratory burst in human neutrophils.

Authors:  R C Jandl; J André-Schwartz; L Borges-DuBois; R S Kipnes; B J McMurrich; B M Babior
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  Inhibition of mushroom tyrosinase by 3-amino-L-tyrosine: molecular probing of the active site of the enzyme.

Authors:  J F Maddaluno; K F Faull
Journal:  Experientia       Date:  1988-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.